PICADOR acquired world rights to a debut novel by Paul Goldberg, editor and publisher of The Cancer Letter. Set in Moscow in late February and early March of 1953, the novel is only in part about medicine. It's expected to be published in early 2016.
ROYAL PHILIPS will analyze pathology samples using advanced image analysis algorithms from Indica Labs Inc. as part of its Digital Pathology Solutions offerings.
THE MEDICAL UNIVERSITY OF SOUTH CAROLINA Hollings Cancer Center's Mount Pleasant location installed TrueBeam imaging capabilities for patients, as well as several types of external beam radiation therapy.
JOHNATHAN LANCASTER joined Myriad Genetics as vice president of medical affairs for oncology in Myriad Genetic Laboratories, effective Feb. 9.
WUXI PHARMATECH (Cayman) Inc. acquired NextCODE Health for $65 million in cash, with plans to merge NextCODE and WuXi's Genome Center into a new company, named WuXi NextCODE Genomics.
CITY OF HOPE and Trovagene Inc. entered into a clinical collaboration to conduct studies on detecting and monitoring EGFR mutations in lung cancer patients using Trovagene's Precision Cancer Monitoring platform.
CARIS LIFE SCIENCES established the Caris Centers of Excellence for Precision Medicine Network, appointing John Marshall as chairman.
THE PANCREATIC CANCER ACTION NETWORK and NCI's Frederick National Laboratory for Cancer Research will award two fellowships to support research on KRAS mutations that are relevant to pancreatic cancer.
SUE BIGGINS was awarded the Edward Novitski Prize by the Genetics Society of America.
GENENTECH and Human Longevity Inc. signed a multi-year agreement to conduct whole genome sequencing of tens of thousands of de-identified samples provided by Genentech, a member of the Roche Group.
